Fig. 3

4, 5-Dimethoxycanthin-6-one inhibits the AKT/mTOR and MAPK signaling pathways. A 4, 5-Dimethoxycanthin-6-one inhibition of the AKT/mTOR and MAPK signaling pathways in U251 cells. B 4, 5-Dimethoxycanthin-6-one inhibition of the AKT/mTOR and MAPK signaling pathways in T98G cells. *P < 0.05 compared with the Control group